Skip to main content

Advertisement

Log in

Potentially inappropriate prescriptions and therapeutic complexity in older HIV patients with comorbidities

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background: The prolonged current survival of human immunodeficiency virus (HIV) patients exposes them to new problems arising from the comorbidities they face. Objectives: To describe the situation of comorbidities, polypharmacy, therapeutic complexity and adherence in people living with HIV over 65 years of age and to assess the presence of potentially inappropriate prescriptions (PIP) by applying deprescription criteria. Methods: Observational study including HIV people (> 65 years) from a university tertiary level hospital. Demographic, clinical and pharmacotherapeutic characteristics of the patients and their treatments were studied. The prevalence of polypharmacy (> 5 medications) and the pharmacotherapy complexity, quantified by the Medication Regimen Complexity Index (MRCI), were calculated. Therapeutic adherence was assessed by the Simplified Medication Adherence Questionnaire (SMAQ) and the medication possession ratio, according to prescription dispensing records. The Screening Tool of Older People’s Prescriptions (STOPP) and List of Evidence-baSed depreScribing for CHRONic patients (LESS-CHRON) criteria were applied to identify PIP. Main outcome measure: PIP in elderly people living with HIV. Results: Thirty patients were included, 73% of whom were men, with a median age of 71 years (IQR 67 − 76) and a median duration of infection of 17 years (IQR, 9 − 21). Seventy percent of the patients suffered from dyslipemia, 66.7% from hypertension, 43.3% from diabetes and 26.7% from mental health disorders. Seventy percent of the patients took more than 5 medications and 30% more than 10. The MRCI of concomitant medications was higher (18.3 points) than the MRCI of antiretroviral therapy (5.1 points), 66.7% of the studied population was classified as adherent. Finally, 70% of the patients present some PIP according to the STOPP or LESS-CHRON criteria. The polypharmacy was significantly associated (p = 0.008) with meeting deprescription criteria. Conclusion: The elderly people living with HIV present numerous comorbidities and met the criteria for polypharmacy. Their pharmacotherapy complexity is mainly determined by the concomitant treatments. There is a high prevalence of meeting deprescription criteria in people living with HIV over the age of 65 and a clear relationship between polypharmacy and deprescription. The optimization of pharmacotherapy is necessary in this population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Collaboration ATC. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV. 2017;4(8):349–56.

    Article  Google Scholar 

  2. Gimeno-Gracia M, Crusells-Canales MJ, Rabanaque-Hernández MJ. Clinical characteristics and antiretroviral treatment of older HIV-infected patients. Int J Clin Pharm. 2014;36:1190–5.

    Article  CAS  Google Scholar 

  3. Blanco JR, Jarrín I, Vallejo M, Berenguer J, Solera C, Rubio R, et al. CoRIS. Definition of advanced age in HIV infection: looking for an age cut-off. AIDS Res Hum Retroviruses. 2012;28(9):1000–6.

    Article  CAS  Google Scholar 

  4. Brañas F, Berenguer J, Sánchez-Conde M, López-B. Quirós JC, Miralles P, Cosín J, et al. The eldest of older adults living with HIV: response and adherente to highly active antiretroviral therapy. Am J Med. 2008;121:820–4.

    Article  Google Scholar 

  5. Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53(11):1120–6.

    Article  Google Scholar 

  6. Reid E, Suneja G, Ambinder RF, et al. Cancer in People Living With HIV, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(8):986–1017.

    Article  Google Scholar 

  7. Manzano-García M, Robustillo-Cortés A, Almeida-Gonzalez CV, Morillo-Verdugo R. Evolution of the Complexity Index of the antiretroviral therapy in HIV+ patients in a real-life clinical practice. Rev Española Quimioter. 2017;30(6):429–35.

    Google Scholar 

  8. George J, Phun YT, Bailey MJ, Kong DCM, Stewart K. Development validation of the medication regimen complexity index. Ann Pharmacother. 2004;38(9):1369–76.

    Article  Google Scholar 

  9. Wimmer BC, Bell JS, Fastborn J, Wiese MD, Johnell K. Medication regimen com- plexity and polypharmacy as factors associated with all-cause mortality in older people: a population-based cohort study. Ann Pharmacother. 2016;50(4):89–95.

    Article  Google Scholar 

  10. Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57–65.

    Article  Google Scholar 

  11. Rodríguez Pérez A, Alfaro Lara ER, Nieto Martín MD, Ruiz Cantero A, Santos RB. Deprescribing in patients with multimorbidity: a necessary process. Eur J Intern Med. 2015;26:18–9.

    Article  Google Scholar 

  12. Delgado Silveira E, Montero Errasquín B, Muñoz García M, Vélez-Díaz-Pallarés M, Lozano Montoya I, Sánchez-Castellano C, et al. [Improving drug prescribing in the elderly: a new edition of STOPP/START criteria]. Rev Esp Geriatr Gerontol. 2015; 50(2): 89–96.

  13. Pastor Cano J, Aranda García A, Gascón Cánovas JJ, Rausell Rausell VJ, Tobaruela SM. Spanish adaptation of the Beers criteria. An Sist Sanit Navar. 2015;38(3):375–85.

    Article  CAS  Google Scholar 

  14. Rodríguez-Pérez A, Alfaro-Lara ER, Albiñana-Perez S, Nieto-Martín MD, Díez-Manglano J, Pérez-Guerrero C, et al. Novel tool for deprescribing in chronic patients with multimorbidity: List of Evidence-Based Deprescribing for Chronic Patients criteria. Geriatr Gerontol Int. 2017;17(11):2200–7.

    Article  Google Scholar 

  15. McNicholl IR, Gandhi M, Hare CB, Greene M, Pierluissi E. A Pharmacist-Led Program to Evaluate and Reduce Polypharmacy and Potentially Inappropriate Prescribing in Older HIV-Positive Patients. Pharmacotherapy. 2017;37(12):1498–506.

    Article  CAS  Google Scholar 

  16. Modelo de Selección y Atención Farmacéutica a Pacientes Crónicos de la Sociedad Española de Farmacia Hospitalaria [Access 16–6–18]. Available at: http://www.sefh.es/bibliotecavirtual/Cronicos/AF_INFORME_PACIENTE_GESTION_SANITARIA.pdf

  17. Morillo-Verdugo R, Martínez-Sesmero JM, Lázaro-López A, Sánchez-Rubio J, Navarro-Aznárez H, DeMiguel-Cascón M. Development of a risk stratification model for pharmaceutical care in HIV patients. Desarrollo de un modelo de estratificación de atención farmacéutica destinado a pacientes VIH. Farm Hosp. 2017;41(3):346–56.

    PubMed  Google Scholar 

  18. Greene M, Steinman MA, McNicholl IR, Valcour V. Polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults with human immunodeficiency virus infection. J Am Geriatr Soc. 2014;62(3):447–53.

    Article  Google Scholar 

  19. Haider SI, Johnell K, Weitoft GR, Thorslund M, Fastbom J. The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people. J Am Geriatr Soc. 2009;57(1):62–9.

    Article  Google Scholar 

  20. Saez de la Fuente J, Such Diaz A, Cañamares-Orbis I, et al. Cross-cultural Adaptation and Validation of the Medication Regimen Complexity Index Adapted to Spanish. Ann Pharmacother. 2016;50(11):918–25.

    Article  Google Scholar 

  21. Panel de Expertos de GeSIDA, Sociedad Española de Farmacia Hospitalaria (SEFH), Plan Nacional sobre el Sida (PNS). Recomendaciones GESIDA/SEFH/PNS para mejorar la adherencia al tratamiento antirretroviral. [Actualización junio 2008]. [Access 15–6–18]. Available at: http://gesida-seimc.org/wp-content/uploads/2017/02/Gesida_dcyrc2008_adherenciaTAR.pdf

  22. Bangsberg DR. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006;43(7):939–41.

    Article  CAS  Google Scholar 

  23. Page AT, Clifford RM, Potter K, Schwartz D, Etherton-Beer CD. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis. Br J Clin Pharmacol. 2016;82(3):583–623.

    Article  Google Scholar 

  24. Moltó J, Miranda C, Malo S, Valle M, Andreu A, Bonafont X, et al. Use of herbal remedies among HIV-infected patients: patterns and correlates. Med Clin (Barc). 2012;138(3):93–8.

    Article  Google Scholar 

  25. Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: The EMPOWER cluster randomized trial. JAMA Intern Med. 2014;174(6):890–8.

    Article  Google Scholar 

  26. Nozza S, Malagoli A, Maia L, Calcagno A, Focà E, De Socio G, et al. Antiretroviral therapy in geriatric HIV patients: The GEPPO cohort study. J Antimicrob Chemother. 2017;72(10):2879–86.

    Article  CAS  Google Scholar 

  27. Metz KR, Fish DN, Hosokawa PW, Hirsch JD, Libby AM. Patient-Level Medication Regimen Complexity in Patients With HIV. Ann Pharmacother. 2014;48(9):1129–37.

    Article  Google Scholar 

  28. Calvo-Cidoncha E, González-Bueno J, Almeida-González CV, Morillo-Verdugo R. Influence of treatment complexity on adherence and incidence of blips in HIV/HCV coinfected patients. J Manag Care Spec Pharm. 2015;21(2):153–7.

    PubMed  Google Scholar 

  29. Robustillo Cortés MLA, Morillo Verdugo R, Barreiro Fernández EM, Pavón Plata A, Monje AP. Influence of hospital admission in the pharmacotherapy complexity of HIV+ patients. Farm Hosp. 2017;41(4):518–26.

    PubMed  Google Scholar 

  30. Cantudo-Cuenca MR, Jiménez-Galán R, Almeida-Gonzalez CV, Morillo-Verdugo R. Concurrent use of comedications reduces adherence to antiretroviral therapy among HIV-infected patients. J Manag Care Spec Pharm. 2014;20:844–50.

    PubMed  Google Scholar 

  31. Gimeno-Gracia M, Sánchez-Rubio-Ferrández J, Robustillo-Cortés MLA, Morillo-Verdugo R. Prevalencia de polifarmacia y complejidad farmacoterapéutica en personas mayores con VIH en España. Estudio POINT Farm Hosp. 2020;44(4):127–34.

    Google Scholar 

Download references

Acknowledgements

We thank Mercedes Gimeno and Sara Malo for the final manuscript. We would especially like to thank all the people that participated in this study.

Funding

There has not been any funding for this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to José Manuel Vinuesa-Hernando.

Ethics declarations

Conflicts of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vinuesa-Hernando, J.M., Gimeno-Gracia, M., Malo, S. et al. Potentially inappropriate prescriptions and therapeutic complexity in older HIV patients with comorbidities. Int J Clin Pharm 43, 1245–1250 (2021). https://doi.org/10.1007/s11096-021-01242-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-021-01242-1

Keywords

Navigation